Malaria: Clinical Trials

7 trials for Malaria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 terminated. 7 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Terminated 7
Phase 23Terminated 3

Follow Malaria: new trials by email Literature Review of Malaria trials Research Report on Malaria

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria
artemether:lumefantrine (2.5 mg:30 mg) - Plasmodium Falciparum Malaria
Phase 2 / Phase 3TerminatedNovartis Pharmaceuticals282020-12-212026-01-13
Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambia
Dihydroartemisinin-piperaquine (DHAP) administered to G6PD deficient, Dihydroartemisinin-piperaquine (DHAP) + 0.25 mg/kg primaquine administered to G6PD deficient, Dihydroartemisinin-piperaquine (DHAP) + 0.4 mg/kg primaquine administered to G6PD deficient - Malaria
Phase 2 / Phase 3TerminatedLondon School of Hygiene and Tropical Medicine612015-12-012016-09-09
The Effectiveness of Non-Pyrethroid Insecticide-Treated Durable Wall Liners as a Method for Malaria Control in Endemic Rural Tanzania
abamectin and fenpyroximate - Malaria
Phase 3TerminatedNational Institute for Medical Research, Tanzania49172015-11-092019-02-05
Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy
Cotrimoxazole, Sulfadoxine-pyrimethamine - Malaria in Pregnancy
Phase 3TerminatedInstitute of Tropical Medicine, Belgium3522009-02-012016-01-18
Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria
Pyronaridine - artesunate, Chloroquine - Malaria
Phase 3TerminatedMedicines for Malaria Venture302007-09-062022-01-26
IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.
sulphadoxine/pyrimethamine, Chlorproguanil/dapsone, Sulfadoxine/pyrimethamine - Malaria
Phase 3TerminatedLondon School of Hygiene and Tropical Medicine1122006-07-012017-01-26
Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia
Azithromycin/Chloroquine, Sulfadoxine-Pyrimethamine/Chloroquine - Malaria, Falciparum
Phase 2 / Phase 3TerminatedPfizer322004-03-012008-11-03

Narrower conditions

Malaria, Falciparum (2)  ·  Malaria, Vivax (1)

Broader conditions

Infections (7)  ·  Mosquito-Borne Diseases (7)  ·  Parasitic Diseases (7)  ·  Protozoan Infections (7)  ·  Vector Borne Diseases (7)

Interventions

fanasil, pyrimethamine drug combination (3)  ·  Chloroquine (2)  ·  Azithromycin (1)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (1)  ·  abamectin (1)  ·  chloroguanil, dapsone drug combination (1)  ·  fenpyroximate (1)  ·  pyronaridine tetraphosphate, artesunate drug combination (1)

Sponsors

London School of Hygiene and Tropical Medicine (2)  ·  Institute of Tropical Medicine, Belgium (1)  ·  Medicines for Malaria Venture (1)  ·  National Institute for Medical Research, Tanzania (1)  ·  Novartis Pharmaceuticals (1)  ·  Pfizer (1)

Countries

Tanzania (2)  ·  Burkina Faso (1)  ·  Democratic Republic of the Congo (1)  ·  South Korea (1)  ·  The Gambia (1)  ·  Zambia (1)

Top investigators

Christine Manyando, MD (1)  ·  Jaqueline Mosha, MD (1)  ·  Joseph P Mugasa, PhD (1)  ·  Roly D Gosling, MD (1)  ·  Samwel Gesase, MD (1)  ·  Stephan Duparc, MD (1)  ·  William N Kisinza, PhD (1)

Results publications

PMID 19238219, PMID 24830749, PMID 27456339, PMID 29324864, PMID 34521374, PMID 39324693, PMID 41199347